Cyclopharm News

Technegas® NDA pending US FDA review

16th Dec 2020

Continue Reading

Cyclopharm partners with McMaster University to Evaluate Technegas® use and risks of COVID-19

4th Mar 2021

Continue Reading

Lung Imaging and COVID-19 Impact

22nd Dec 2020

Continue Reading

FNN Interview

22nd Dec 2020

Continue Reading

Technegas USA Trial Successfully Meets Primary Endpoint

15th Sep 2020

Continue Reading

Cyclopharm AGM 2020

10th Jul 2020

Continue Reading

USFDA Approval to File Received for Technegas™

27th May 2020

Continue Reading

Technegas™ approved in Russia

26th May 2020

Continue Reading

Clinical research opportunity in COVID-19

4th May 2020

Continue Reading

USFDA Fee Waiver for Technegas™ Application

14th Apr 2020

Continue Reading

Cyclopharm submits FDA approval for Technegas™

7th Apr 2020

Continue Reading

Cyclopharm Lodges NDA for Technegas® with the USFDA

30th Mar 2020

Continue Reading

Technegas™ is not an aerosol generating procedure

23rd Mar 2020

Continue Reading

Technegas™ and Covid-19

20th Mar 2020

Continue Reading

TechKnow Invest Roadshow

21st Oct 2019

Continue Reading

1
2
3
Next »

Copyright © Cyclopharm 2021 | Last Updated: March 8, 2019 Privacy Policy